Thorax podcast show

Thorax podcast

Summary: From June 2023, all our podcasts will move to https://thoraxbmj.podbean.com. You can continue with your subscription on your favourite podcast App. Thorax, the official journal of the British Thoracic Society, publishes influential clinical and experimental research in respiratory medicine, paediatrics, immunology, pharmacology, pathology, and surgery. The focus is on work that advances scientific understanding and impacts clinical practice. http://thorax.bmj.com/ * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Podcasts:

 Growing up on a farm as related to adult lung function and allergic phenotypes | File Type: audio/mpeg | Duration: 7:55

In this podcast Jennifer Quint talks to Shyamali Dharmage and Brittany Campbell about their recent press released paper "Growing up on a farm as related to adult lung function and allergic phenotypes: An international population based study".

 Growing up on a farm as related to adult lung function and allergic phenotypes | File Type: audio/mpeg | Duration: 7:55

In this podcast Jennifer Quint talks to Shyamali Dharmage and Brittany Campbell about their recent press released paper "Growing up on a farm as related to adult lung function and allergic phenotypes: An international population based study".

 Air Pollution affects Lung Cancer Survival | File Type: audio/mpeg | Duration: 5:15

Patients exposed to air pollution after diagnosis of lung cancer have shorter survival, in particular those patients with early-stage non-small cell cancers (specially adenocarcinomas), according to a study published by Thorax and conducted by researchers from the Department of Preventive Medicine, University of Southern California. The first study of this kind was based on a population of over 300 thousand patients with newly diagnosed lung cancer over more than two decades. In this podcast, Dr Jaime Hart, from the Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School and author of the Thorax editorial about this study, tells Dr Jennifer Quint the details of this study and its impact on how air pollution is considered by general population. Read the original article ’Air pollution affects lung cancer survival’, which corresponding author is Dr Sandrah P Eckel, here: http://thorax.bmj.com/content/early/2016/06/22/thoraxjnl-2015-207927.full. The editorial is available here: http://thorax.bmj.com/content/early/2016/07/20/thoraxjnl-2016-208967.full.

 Air Pollution affects Lung Cancer Survival | File Type: audio/mpeg | Duration: 5:15

Patients exposed to air pollution after diagnosis of lung cancer have shorter survival, in particular those patients with early-stage non-small cell cancers (specially adenocarcinomas), according to a study published by Thorax and conducted by researchers from the Department of Preventive Medicine, University of Southern California. The first study of this kind was based on a population of over 300 thousand patients with newly diagnosed lung cancer over more than two decades. In this podcast, Dr Jaime Hart, from the Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School and author of the Thorax editorial about this study, tells Dr Jennifer Quint the details of this study and its impact on how air pollution is considered by general population. Read the original article ’Air pollution affects lung cancer survival’, which corresponding author is Dr Sandrah P Eckel, here: http://thorax.bmj.com/content/early/2016/06/22/thoraxjnl-2015-207927.full. The editorial is available here: http://thorax.bmj.com/content/early/2016/07/20/thoraxjnl-2016-208967.full.

 Air pollution and the London low emission zone | File Type: audio/mpeg | Duration: 14:30

In this podcast Dr Ian Mudway talks to Dr Elizabeth Batalla-Duran about his recent paper in Plos-One entitled "Effects of air pollution and introduction of the London low emission zone on the prevalence of respiratory and allergic symptoms on the school children of East London".

 Air pollution and the London low emission zone | File Type: audio/mpeg | Duration: 14:30

In this podcast Dr Ian Mudway talks to Dr Elizabeth Batalla-Duran about his recent paper in Plos-One entitled "Effects of air pollution and introduction of the London low emission zone on the prevalence of respiratory and allergic symptoms on the school children of East London".

 E-cigarette use and smoking in early adolescence | File Type: audio/mpeg | Duration: 14:01

In this podcast Dr Elizabeth Batalla-Duran talks to Dr Adam Leventhal from the University Southern California about his paper "Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence" recently published in JAMA.

 E-cigarette use and smoking in early adolescence | File Type: audio/mpeg | Duration: 14:01

In this podcast Dr Elizabeth Batalla-Duran talks to Dr Adam Leventhal from the University Southern California about his paper "Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence" recently published in JAMA.

 Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease | File Type: audio/mpeg | Duration: 9:34

In this podcast Dr Janice Higginson talks to Dr Helena Anderson from Oslo University Hospital about her recent paper published in Rheumatology. The paper is a retrospective review of research done into rituximab's effect on the rare Antisynthetase Syndrome.

 Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease | File Type: audio/mpeg | Duration: 9:34

In this podcast Dr Janice Higginson talks to Dr Helena Anderson from Oslo University Hospital about her recent paper published in Rheumatology. The paper is a retrospective review of research done into rituximab's effect on the rare Antisynthetase Syndrome.

 Pneumococcal vaccination for welders | File Type: audio/mpeg | Duration: 9:11

Thorax deputy editor Paul Cullinan talks to David Coggon, MRC Lifecourse Epidemiology Unit, University of Southampton, about pneumococcal vaccination for welders. Read the full article: http://goo.gl/p3qN8s

 Pneumococcal vaccination for welders | File Type: audio/mpeg | Duration: 9:11

Thorax deputy editor Paul Cullinan talks to David Coggon, MRC Lifecourse Epidemiology Unit, University of Southampton, about pneumococcal vaccination for welders. Read the full article: http://goo.gl/p3qN8s

 The genomic origins of asthma | File Type: audio/mpeg | Duration: 14:08

Ian Pavord talks to Scott Weiss, Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, about his review on the genomic origins of asthma, which considers several areas where environmental exposures, genomics, development and asthma occurrence overlap. Read the full review: http://goo.gl/KctouZ

 The genomic origins of asthma | File Type: audio/mpeg | Duration: 14:08

Ian Pavord talks to Scott Weiss, Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, about his review on the genomic origins of asthma, which considers several areas where environmental exposures, genomics, development and asthma occurrence overlap. Read the full review: http://goo.gl/KctouZ

 The promise of translational and personalised approaches for paediatric obstructive sleep apnoea | File Type: audio/mpeg | Duration: 19:34

Obstructive sleep apnoea (OSA) can result in significant morbidities including the cardiovascular, metabolic and neurocognitive systems. While great advances have been made in sleep medicine research in the past decades, there are still wide gaps in our knowledge concerning the exact underlying pathophysiological mechanisms of OSA and consequences. A recent review in Thorax discusses the recent exciting discoveries in genotype-phenotype interactions, epigenetics, genomics and proteomics related to OSA. Thorax editor Andy Bush talks to co-author David Gozal, professor in the Department of Pediatrics, The University of Chicago, about the highlights.Read the full paper:The promise of translational and personalised approaches for paediatric obstructive sleep apnoea: an ‘Omics’ perspective http://goo.gl/fKf28O

Comments

Login or signup comment.